We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vornado (VNO) Surges 10.3%: Is This an Indication of Further Gains?
Read MoreHide Full Article
Vornado (VNO - Free Report) shares rallied 10.3% in the last trading session to close at $35.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.8% loss over the past four weeks.
The increased investor optimism in the stock can be attributed to President Donald Trump’s recent announcement to put a 90-day pause on the reciprocal tariff for most countries.
This real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.52 per share in its upcoming report, which represents a year-over-year change of -5.5%. Revenues are expected to be $450.05 million, up 3.1% from the year-ago quarter.
While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO per share estimate revisions and near-term stock price movements.
For Vornado, the consensus FFO per share estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. And a positive trend in FFO per share estimate revision usually translates into price appreciation. So, make sure to keep an eye on VNO going forward to see if this recent jump can turn into more strength down the road.
Vornado is part of the Zacks REIT and Equity Trust - Other industry. Healthpeak (DOC - Free Report) , another stock in the same industry, closed the last trading session 3.6% higher at $18.64. DOC has returned -11.5% in the past month.
For Healthpeak, the consensus FFO per share estimate for the upcoming report has changed +0.4% over the past month to $0.46. This represents a change of +2.2% from what the company reported a year ago. Healthpeak currently has a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Vornado (VNO) Surges 10.3%: Is This an Indication of Further Gains?
Vornado (VNO - Free Report) shares rallied 10.3% in the last trading session to close at $35.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.8% loss over the past four weeks.
The increased investor optimism in the stock can be attributed to President Donald Trump’s recent announcement to put a 90-day pause on the reciprocal tariff for most countries.
This real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.52 per share in its upcoming report, which represents a year-over-year change of -5.5%. Revenues are expected to be $450.05 million, up 3.1% from the year-ago quarter.
While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO per share estimate revisions and near-term stock price movements.
For Vornado, the consensus FFO per share estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. And a positive trend in FFO per share estimate revision usually translates into price appreciation. So, make sure to keep an eye on VNO going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Vornado is part of the Zacks REIT and Equity Trust - Other industry. Healthpeak (DOC - Free Report) , another stock in the same industry, closed the last trading session 3.6% higher at $18.64. DOC has returned -11.5% in the past month.
For Healthpeak, the consensus FFO per share estimate for the upcoming report has changed +0.4% over the past month to $0.46. This represents a change of +2.2% from what the company reported a year ago. Healthpeak currently has a Zacks Rank of #3 (Hold).